Medication info
Sita Tablet 50 mg (Sitagliptin Phosphate Monohydrate)

Sita Tablet 50 mg (Sitagliptin Phosphate Monohydrate)

Prescription medicationTabletOral
Ingredient · strength
Sitagliptin Phosphate Hydrate›64.25mg / 1 tablet
Manufacturer / importer
Hanmi Pharmaceutical Co., Ltd.
Appearance
Yellow, round, biconvex film-coated tablet
Packaging
30 tablets/box [10 tablets/PTPX3]
Approval status
Active

MFDS item code 201504252 · Approved 2015.06.30 · Insurance code 643507300

Summary

Main use
Improvement of glycemic control in type 2 diabetes mellitus
Who takes it
Adults
Adult dose
This drug is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This drug may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia. (See Precautions for Use, section 5, General Precautions.) Patients with renal impairment Because dose adjustment is required according to renal function, assessment of renal function before treatment with this drug and periodically during treatment is recommended. 1. No dose adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This drug may be administered regardless of the timing of dialysis.

Ingredients

Manufacturer
Hanmi Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of glycemic control in type 2 diabetes mellitus

View approved original text

This medication is used in conjunction with diet and exercise to help patients with type 2 diabetes manage their blood sugar levels more effectively. It can be used alone or in combination with other diabetes medications. This helps improve blood sugar management and aids in controlling symptoms of diabetes. Therefore, this medication is used for blood sugar control in patients with type 2 diabetes.

How to take

Adult dose

This drug is administered at 100 mg once daily as monotherapy or in combination therapy; the maximum daily dose is 100 mg. This drug may be taken with or without food. When coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of sulfonylurea- or insulin-induced hypoglycemia. (See Precautions for Use, section 5, General Precautions.) Patients with renal impairment Because dose adjustment is required according to renal function, assessment of renal function before treatment with this drug and periodically during treatment is recommended. 1. No dose adjustment is required in patients with mild renal impairment (glomerular filtration rate [eGFR] ≥ 60mL/min/1.73 m2 and < 90 mL/min/1.73 m2). 2. No dose adjustment is required in patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 45mL/min/1.73 m2 and < 60mL/min/1.73 m2). 3. Administer 50 mg once daily to patients with moderate renal impairment (glomerular filtration rate [eGFR] ≥ 30mL/min/1.73 m2 and < 45mL/min/1.73 m2). 4. Administer 25 mg once daily to patients with severe renal impairment (glomerular filtration rate [eGFR] ≥ 15mL/min/1.73 m2 and < 30mL/min/1.73 m2) or end-stage renal disease (ESRD) requiring hemodialysis or peritoneal dialysis (glomerular filtration rate [eGFR] < 15 mL/min/1.73 m2). This drug may be administered regardless of the timing of dialysis.

Precautions

This medication may cause serious allergic reactions, so if symptoms such as skin rash, difficulty breathing, or swelling of the face or neck occur, discontinue use immediately and consult a healthcare professional. During treatment, acute pancreatitis may occur, so if symptoms such as abdominal pain, nausea, or vomiting arise, promptly visit a hospital. Patients with type 1 diabetes or diabetic ketoacidosis should not take this medication. Avoid this medication if you have an allergy to it or its components. Patients with decreased kidney function must adjust the dose of this medication and take it according to a doctor's instructions. When taking this medication with other blood glucose-lowering agents, there may be an increased risk of hypoglycemia, so be alert for symptoms of hypoglycemia and check blood sugar levels frequently if needed. Symptoms such as headaches, upper respiratory infections, nasopharyngitis, indigestion, diarrhea, nausea, increased blood triglycerides, gastritis, weight loss, hypertension, hypernatremia, and erectile dysfunction may occur during treatment; report any severe or persistent symptoms to your doctor. If severe joint pain or blistering skin symptoms occur, discontinue this medication immediately and consult a healthcare professional. Pregnant or nursing women are advised not to take this medication, and the safety and efficacy for children or adolescents under 18 years have not been adequately confirmed. Older adults should undergo kidney function tests before taking this medication, as kidney function may decline, and should regularly monitor kidney function during treatment. In the case of overdose, immediately go to a hospital for appropriate treatment; this medication can be partially removed through hemodialysis, so dialysis treatment may be considered if necessary.

Side effects

  • Severe hypersensitivity reactions
  • anaphylaxis
  • angioedema
  • Stevens-Johnson syndrome
  • exfoliative skin disease
  • acute pancreatitis
  • hypoglycemia
  • upper respiratory infection
  • nasopharyngitis
  • headache
Show 28 more
  • diarrhea
  • abdominal pain
  • nausea
  • peripheral edema
  • constipation
  • vomiting
  • severe arthralgia with disability
  • bullous pemphigoid
  • myalgia
  • limb pain
  • back pain
  • interstitial lung disease
  • pruritus
  • thrombocytopenia
  • rhabdomyolysis
  • elevated liver enzymes
  • acute renal failure
  • pneumonia
  • diabetic complications
  • metabolic acidosis
  • falls
  • cardiac arrest
  • dyspepsia
  • dizziness
  • increased serum triglycerides
  • gastritis
  • increased low-density lipoprotein
  • hyperglycemia

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent air exposure, at room temperature between 1°C and 30°C. Proper storage will help maintain the efficacy of the medication and prevent deterioration.

Appearance and packaging

Appearance

Yellow, round, biconvex film-coated tablet

Package unit

30 tablets/box [10 tablets/PTPX3]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.